Yes OPC that seems likely.

My point was that many folks look at places like China and other BRIC countries and make the false assumption that because diabetes is out of control there they will be able to afford Afrezza as a treatment. IMO unless the government subsidizes it places like India are unlikely to use the drug. I found it humorous that the GNBT cheerleaders expected their drug to take off there when it used as much as 5X the insulin as Afrezza. Their drug was hexameric insulin to boot and they had to cheat to get it into the country.

My point was that despite the potential global market for Afrezza, the ROW potential is limited by those who can afford it. Simply saying half a billion worldwide could benefit from Afrezza does not mean that all of them will ever have that chance.

Swing